These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

225 related items for PubMed ID: 20599715

  • 1. cAMP-response-element-binding protein positively regulates breast cancer metastasis and subsequent bone destruction.
    Son J, Lee JH, Kim HN, Ha H, Lee ZH.
    Biochem Biophys Res Commun; 2010 Jul 23; 398(2):309-14. PubMed ID: 20599715
    [Abstract] [Full Text] [Related]

  • 2. Bone morphogenetic protein 7 in the development and treatment of bone metastases from breast cancer.
    Buijs JT, Henriquez NV, van Overveld PG, van der Horst G, Que I, Schwaninger R, Rentsch C, Ten Dijke P, Cleton-Jansen AM, Driouch K, Lidereau R, Bachelier R, Vukicevic S, Clézardin P, Papapoulos SE, Cecchini MG, Löwik CW, van der Pluijm G.
    Cancer Res; 2007 Sep 15; 67(18):8742-51. PubMed ID: 17875715
    [Abstract] [Full Text] [Related]

  • 3. Humanized monoclonal antibody against parathyroid hormone-related protein suppresses osteolytic bone metastasis of human breast cancer cells derived from MDA-MB-231.
    Saito H, Tsunenari T, Onuma E, Sato K, Ogata E, Yamada-Okabe H.
    Anticancer Res; 2005 Sep 15; 25(6B):3817-23. PubMed ID: 16309168
    [Abstract] [Full Text] [Related]

  • 4. A bone-seeking clone exhibits different biological properties from the MDA-MB-231 parental human breast cancer cells and a brain-seeking clone in vivo and in vitro.
    Yoneda T, Williams PJ, Hiraga T, Niewolna M, Nishimura R.
    J Bone Miner Res; 2001 Aug 15; 16(8):1486-95. PubMed ID: 11499871
    [Abstract] [Full Text] [Related]

  • 5. Monitoring metastatic behavior of human tumor cells in mice with species-specific polymerase chain reaction: elevated expression of angiogenesis and bone resorption stimulators by breast cancer in bone metastases.
    van der Pluijm G, Sijmons B, Vloedgraven H, Deckers M, Papapoulos S, Löwik C.
    J Bone Miner Res; 2001 Jun 15; 16(6):1077-91. PubMed ID: 11393785
    [Abstract] [Full Text] [Related]

  • 6. Osteoprotegerin overexpression by breast cancer cells enhances orthotopic and osseous tumor growth and contrasts with that delivered therapeutically.
    Fisher JL, Thomas-Mudge RJ, Elliott J, Hards DK, Sims NA, Slavin J, Martin TJ, Gillespie MT.
    Cancer Res; 2006 Apr 01; 66(7):3620-8. PubMed ID: 16585187
    [Abstract] [Full Text] [Related]

  • 7. Expression of interleukin 8 and not parathyroid hormone-related protein by human breast cancer cells correlates with bone metastasis in vivo.
    Bendre MS, Gaddy-Kurten D, Mon-Foote T, Akel NS, Skinner RA, Nicholas RW, Suva LJ.
    Cancer Res; 2002 Oct 01; 62(19):5571-9. PubMed ID: 12359770
    [Abstract] [Full Text] [Related]

  • 8. Bone morphogenetic protein signaling enhances invasion and bone metastasis of breast cancer cells through Smad pathway.
    Katsuno Y, Hanyu A, Kanda H, Ishikawa Y, Akiyama F, Iwase T, Ogata E, Ehata S, Miyazono K, Imamura T.
    Oncogene; 2008 Oct 23; 27(49):6322-33. PubMed ID: 18663362
    [Abstract] [Full Text] [Related]

  • 9. E-cadherin expression in human breast cancer cells suppresses the development of osteolytic bone metastases in an experimental metastasis model.
    Mbalaviele G, Dunstan CR, Sasaki A, Williams PJ, Mundy GR, Yoneda T.
    Cancer Res; 1996 Sep 01; 56(17):4063-70. PubMed ID: 8752180
    [Abstract] [Full Text] [Related]

  • 10. The tumor suppressor Smad4 is required for transforming growth factor beta-induced epithelial to mesenchymal transition and bone metastasis of breast cancer cells.
    Deckers M, van Dinther M, Buijs J, Que I, Löwik C, van der Pluijm G, ten Dijke P.
    Cancer Res; 2006 Feb 15; 66(4):2202-9. PubMed ID: 16489022
    [Abstract] [Full Text] [Related]

  • 11. CREB-1 and AP-1 transcription factors JunD and Fra-2 regulate bone sialoprotein gene expression in human breast cancer cells.
    Detry C, Lamour V, Castronovo V, Bellahcène A.
    Bone; 2008 Feb 15; 42(2):422-31. PubMed ID: 18088579
    [Abstract] [Full Text] [Related]

  • 12. Transforming growth factor-beta1 is the predominant isoform required for breast cancer cell outgrowth in bone.
    Mourskaia AA, Dong Z, Ng S, Banville M, Zwaagstra JC, O'Connor-McCourt MD, Siegel PM.
    Oncogene; 2009 Feb 19; 28(7):1005-15. PubMed ID: 19079339
    [Abstract] [Full Text] [Related]

  • 13. PTHrP regulates angiogenesis and bone resorption via VEGF expression.
    Isowa S, Shimo T, Ibaragi S, Kurio N, Okui T, Matsubara K, Hassan NM, Kishimoto K, Sasaki A.
    Anticancer Res; 2010 Jul 19; 30(7):2755-67. PubMed ID: 20683010
    [Abstract] [Full Text] [Related]

  • 14. Transforming growth factor-beta in osteolytic breast cancer bone metastases.
    Guise TA, Chirgwin JM.
    Clin Orthop Relat Res; 2003 Oct 19; (415 Suppl):S32-8. PubMed ID: 14600590
    [Abstract] [Full Text] [Related]

  • 15. Tumor-derived interleukin-8 stimulates osteolysis independent of the receptor activator of nuclear factor-kappaB ligand pathway.
    Bendre MS, Margulies AG, Walser B, Akel NS, Bhattacharrya S, Skinner RA, Swain F, Ramani V, Mohammad KS, Wessner LL, Martinez A, Guise TA, Chirgwin JM, Gaddy D, Suva LJ.
    Cancer Res; 2005 Dec 01; 65(23):11001-9. PubMed ID: 16322249
    [Abstract] [Full Text] [Related]

  • 16. Stimulation of cyclooxygenase-2 expression by bone-derived transforming growth factor-beta enhances bone metastases in breast cancer.
    Hiraga T, Myoui A, Choi ME, Yoshikawa H, Yoneda T.
    Cancer Res; 2006 Feb 15; 66(4):2067-73. PubMed ID: 16489006
    [Abstract] [Full Text] [Related]

  • 17. RANK ligand is a prerequisite for cancer-associated osteolytic lesions.
    Kitazawa S, Kitazawa R.
    J Pathol; 2002 Oct 15; 198(2):228-36. PubMed ID: 12237883
    [Abstract] [Full Text] [Related]

  • 18. Osteoprotegerin inhibits osteolysis and decreases skeletal tumor burden in syngeneic and nude mouse models of experimental bone metastasis.
    Morony S, Capparelli C, Sarosi I, Lacey DL, Dunstan CR, Kostenuik PJ.
    Cancer Res; 2001 Jun 01; 61(11):4432-6. PubMed ID: 11389072
    [Abstract] [Full Text] [Related]

  • 19. Astrocyte-derived cytokines contribute to the metastatic brain specificity of breast cancer cells.
    Sierra A, Price JE, García-Ramirez M, Méndez O, López L, Fabra A.
    Lab Invest; 1997 Oct 01; 77(4):357-68. PubMed ID: 9354770
    [Abstract] [Full Text] [Related]

  • 20. Nuclear factor-kappaB-dependent mechanisms in breast cancer cells regulate tumor burden and osteolysis in bone.
    Gordon AH, O'Keefe RJ, Schwarz EM, Rosier RN, Puzas JE.
    Cancer Res; 2005 Apr 15; 65(8):3209-17. PubMed ID: 15833852
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.